IHS Chemical Week

Regions :: North America :: U.S.

Watson Pharmaceuticals Acquires Strides Arcolab’s Generics Business in Australia and Southeast Asia for $393 Million

2:22 AM MST | January 24, 2012 | Deepti Ramesh

Watson Pharmaceuticals (Parsippany, NJ) and Strides Arcolab (Bangalore, India) say that Watson has acquired Ascent Pharmahealth (Melbourne), the generic pharmaceutical business of Strides Arcolab in Australia and Southeast Asia for A$375 million ($393 million) in cash. Ascent is one of the top five generic pharmaceutical companies in Australia and is present across several countries in Southeast Asia, including Singapore where it is the leading generic pharmaceutical company. With the acquisition, Watson becomes the fifth largest generic pharma company in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa